Cargando…
Treatment options and outcomes for glioblastoma in the elderly patient
Age remains the most powerful prognostic factor among glioblastoma (GBM) patients. Half of all patients with GBM are aged 65 years or older at the time of diagnosis, and the incidence rate of GBM in patients aged over 65 years is increasing rapidly. Median survival for elderly GBM patients is less t...
Autores principales: | Arvold, Nils D, Reardon, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937103/ https://www.ncbi.nlm.nih.gov/pubmed/24591820 http://dx.doi.org/10.2147/CIA.S44259 |
Ejemplares similares
-
Recurrent glioblastoma in elderly: Options and decision for the treatment
por: Prajapati, Hanuman Prasad, et al.
Publicado: (2022) -
Recurrent Glioblastoma: A Review of the Treatment Options
por: Vaz-Salgado, Maria Angeles, et al.
Publicado: (2023) -
Glioblastoma Treatment in the Elderly
por: OKADA, Masaki, et al.
Publicado: (2017) -
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
por: Yalamarty, Satya Siva Kishan, et al.
Publicado: (2023) -
Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis
por: Mantziari, Styliani, et al.
Publicado: (2021)